GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

A scientist has explained why 'healthy people' who are taking GLP-1 drugs are actually 'part of the experiment' as the drug ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...

USDA data shows snack sales holding steady in 2024, even as GLP-1 weight loss drug use rises, highlighting shifting consumer ...

GLP-1 therapies continue to reshape chronic disease treatment, triggering regulatory updates, new clinical findings and intensifying competition across the pharmaceutical market. On Jan. 13, the FDA ...

Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...

Whether it's about promoting protein or smaller portions, the restaurant industry is preparing for a shift in consumer ...

GLP-1 class obesity treatments such as Wegovy and Mounjaro may reduce the risk of alcohol or drug addiction, according to a new study. Experts suggest this indicates potential for obesity medications ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...